ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,769.70
0.00%
S&P ASX All Technology
3,089.10
0.00%
Brent Oil
84.695
-0.11%
US Dollar vs AUD
1.49813
-0.21%
Bitcoin
64,923.72
-0.33%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Phoenix Biotech Aquisition Corporation (PBAXU)

  7. Phoenix Biotech Aquisition Corporation (PBAXU) News

PBAXU

Phoenix Biotech Aquisition (PBAXU)

Phoenix Biotech Aquisition Corporation
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PBAXU
DateTimeSourceHeadlineSymbolCompany
06/06/202407:13Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
22/05/202422:00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
18/05/202407:09Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
16/05/202420:28Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
07/05/202407:11Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
04/05/202406:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
02/05/202414:16Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
02/05/202406:45Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
02/05/202406:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
27/04/202406:31Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
16/04/202406:36Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
11/04/202406:06Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
04/04/202408:27Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
02/04/202422:12Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
02/04/202422:07Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
02/04/202412:54Edgar (US Regulatory)Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
28/03/202412:28Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
28/03/202412:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
29/02/202401:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
28/02/202400:27Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
27/02/202413:37Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
24/02/202409:13Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
21/02/202409:18Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
17/02/202411:38Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
17/02/202411:29Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
17/02/202411:28Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
15/02/202404:14Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
15/02/202404:12Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
13/02/202408:16Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
13/02/202408:14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PBAXUPhoenix Biotech Aquisition Corporation
 Showing the most relevant articles for your search:NASDAQ:PBAXU

Your Recent History

FX
AUDUSD
AUD vs US Dollar
ASX
WPL
Woodside Petroleum
ASX
WBC
Westpac Banking
NYSE
XOM
Exxon Mobil
COIN
BTCUSD
Bitcoin
ASX
ORG
Origin Energy
NYSE
NKE
Nike
ASX
XTO
S&P ASX 100
ASX
CBA
Commonwealth Bank Of Aus...
NYSE
DIS
Walt Disney
NASDAQ
TSLA
Tesla
ASX
NCM
Newcrest Mining
ASX
BHP
BHP
FX
EURAUD
Euro vs AUD
ASX
WES
Wesfarmers
ASX
CSL
CSL
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved